Rupen Desai

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Cerebrospinal Fluid

Top Venues

Journal for immunotherapy of cancer

International journal of molecular sciences

Operative neurosurgery (Hagerstown, Md.)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Rupen Desai, Panayiotis E Pelargos, Ian F Dunn
Chordoma: Genetics and Contemporary Management. International journal of molecular sciences 25 (11) (2024)
Rupen Desai, Panayiotis E Pelargos, Ian F Dunn
Chordoma: Genetics and Contemporary Management. International journal of molecular sciences 25 (11) (2024)
Rupen Desai, Victor Ramzes Chavez-Herrera, Steven Zeldin, Gulce Gel, Kyle J Godfrey, Theodore H Schwartz
Lateral Transorbital Endoscope-Assisted Resection of Anterior Temporal Lobe Neoplasm: 2-Dimensional Operative Video. Operative neurosurgery (Hagerstown, Md.) (2024)
Rupen Desai, Panayiotis E Pelargos, Ian F Dunn
Chordoma: Genetics and Contemporary Management. International journal of molecular sciences 25 (11) (2024)
Maximilian O Schaettler, Rupen Desai, Anthony Z Wang, Alexandra J Livingstone, Dale K Kobayashi, Andrew T Coxon, Jay A Bowman-Kirigin, Connor J Liu, Mao Li, Diane E Bender, Michael J White, David M Kranz, Tanner M Johanns, Gavin P Dunn
TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma. Journal for immunotherapy of cancer 11 (2) (2023)
Saad M Khan, Rupen Desai, Andrew Coxon, Alexandra Livingstone, Gavin P Dunn, Allegra Petti, Tanner M Johanns
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Journal for immunotherapy of cancer 10 (12) (2022)
Saad M Khan, Rupen Desai, Andrew Coxon, Alexandra Livingstone, Gavin P Dunn, Allegra Petti, Tanner M Johanns
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Journal for immunotherapy of cancer 10 (12) (2022)
Saad M Khan, Rupen Desai, Andrew Coxon, Alexandra Livingstone, Gavin P Dunn, Allegra Petti, Tanner M Johanns
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Journal for immunotherapy of cancer 10 (12) (2022)
Saad M Khan, Rupen Desai, Andrew Coxon, Alexandra Livingstone, Gavin P Dunn, Allegra Petti, Tanner M Johanns
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Journal for immunotherapy of cancer 10 (12) (2022)
Jay A Bowman-Kirigin, Rupen Desai, Brian T Saunders, Anthony Z Wang, Maximilian O Schaettler, Connor J Liu, Alexandra J Livingstone, Dale K Kobayashi, Vivek Durai, Nicole M Kretzer, Gregory J Zipfel, Eric C Leuthardt, Joshua W Osbun, Michael R Chicoine, Albert H Kim, Kenneth M Murphy, Tanner M Johanns, Bernd H Zinselmeyer, Gavin P Dunn
The conventional dendritic cell 1 subset primes CD8+ T cells and traffics tumor antigen to drive anti-tumor immunity in the brain. Cancer immunology research (2022)
Saad M Khan, Rupen Desai, Andrew Coxon, Alexandra Livingstone, Gavin P Dunn, Allegra Petti, Tanner M Johanns
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Journal for immunotherapy of cancer 10 (12) (2022)
Rupen Desai, Anja I Srienc, Robi N Maamari, Philip L Custer, David K Warren, Michael R Chicoine
Removal of a Penetrating Tree Branch in the Orbitofrontal Region-A Unique Application of an Orbitofrontal Craniotomy Through a Supraciliary Brow Approach. Operative neurosurgery (Hagerstown, Md.) 21 (4) (2021)
Carter M Suryadevara, Rupen Desai, S Harrison Farber, Bryan D Choi, Adam M Swartz, Steven H Shen, Patrick C Gedeon, David J Snyder, James E Herndon, Patrick Healy, Elizabeth A Reap, Gary E Archer, Peter E Fecci, John H Sampson, Luis Sanchez-Perez
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1) (2018)